RA Prelecture Flashcards

1
Q

What is RA?

A

● Immune-mediated systemic inflammatory joint disease
○ Immune system targets synovium (and sometimes other internal organs)
causing pain, swelling, inflammation, and joint destruction
○ Hallmark: persistent symmetric synovial proliferation & tenderness of
multiple joints, particularly in the hands and feet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Epidemiology

A

● Prevalence
○ 1% overall, affecting 300,000 Canadians
○ ↑ with age
○ most commonly diagnosed between 25-50y
● Affects more females than males, approximately 3:1
● Health care costs ~3x higher than age & sex-matched controls
● Prognosis
○ historically poor, with progressive joint damage and deformity
■ acute &/or chronic pain
■ erosions on X-ray à deformities
■ long-term disability
○ reduced life expectancy

We are doing a better job managing it now
female patients tend
to be diagnosed at a younger age
compared to males who are often
diagnosed in their 50s 60s or even 70s
Pt lifespan remains approx 10yrs shorter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Etiology and Risk Factors

A

● Genetics
○ disease specific genes
■ T lymphocytes with HLA-DR4 or HLA-DR1 variation
● Host Factors
○ pregnancy
● Environmental Factors
○ smoking
○ viral infection
○ air pollution

HLA is an MHC
class II molecule that presents foreign
antigen to T cells initiating an immune
response to a foreign invader

more commonly
diagnosed in the year following a
pregnancy and patients who are pregnant
often experience an improvement in
symptoms

smoking being
the strongest known environmental risk
Factor

viral infections have also long been
suspected but never proven

air pollution
is the other one that’s difficult to
prove but incident rates tend to be
higher in communities where there is
worse air quality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Pathophysiology: Phases of Early RA

A

external trigger leads to autoimmune reaction in genetically susceptible individual
Rheumatoid Factor (RF)
Anti-citrullinated protein antibody (ACPA)

Chronic inflammation leads to synovial changes
○ presence of pannus: thickened, inflamed joint lining
■ invades cartilage & bone surface, leading to erosions and permanent joint
destruction (deformities)
○ influx of inflammatory cells in the synovial fluid
■ T-lymphocytes, B-lymphocytes, cytokines, etc
○ angiogenesis
■ further enables inflammatory response

Cascade of inflammation and destruction
the synovium or joint lining which is
usually just one to two layers thick
becomes infiltrated with various
inflammatory cell types due to altered
production and regulation of those
cytokines

as it gets thickened
and sort of established as an inflamed
joint lining we call pannus
eventually that pannus shoves its way
into cartilage and Bone leading to Joint
destruction
-

release of vasoactive substances like
histamine and prostaglandins and kinins
increase the permeability of the
vasculature bringing more inflammatory
mediators to the joints and leading to
the red hot swollen joints

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pathophysiology w lymphocites

A

Activated T-lymphocytes
Stimulate release of macrophages or
monocytes
Ø release of cytotoxins and inflammatory cytokines
Activate osteoclasts Ø degrade bone
Activate release of MMPs Ø degrade connective tissue
Stimulate B-lymphocytes

Activated B-lymphocytes
Produce autoantibodies Ø rheumatoid factor (antibody to Ig)
Ø anti-citrullinated protein antibody (ACPA)
Serve as antigen presenting cells to
T lymphocytes
Ø perpetuate the inflammatory response
Produce pro-inflammatory cytokines Ø Further stimulate fibroblasts, osteoclasts, MMPs
Ø cellular damage to synovium and bone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pathophysiology
● Cytokines

A

○ imbalance leads to inflammation and joint destruction
ANTI-Inflammatory
* IL-1RA
* IL-4
* IL-10
PRO-Inflammatory
* TNFa
* IL-1
* IL-6
* IL-8
* IL-17

tnf Alpha and il-6 as
the two dominant pro-inflammatory
players
Also targeted by drug tx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

RA Joint Adaption and Destruction

A

Normal Joint Rheumatoid Joint

swelling
within the joint capsule with
neutrophils and macrophages and B cells
and T cells and other immune cells all
present that synovial lining is thick
and you can see that that panus is
pushing its way into the bone and eating
away at the cartilage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Clinical Presentation

A

● Onset:
○ insidious (usually over weeks or months)
● Distribution:
○ usually initially oligoarticular, progressing to polyarthritis
○ can affect almost any joint, symmetrical in presentation
○ most common: small joints of hands & feet
● Symptoms:
○ morning stiffness (‘gelling’) for >1h
○ symmetric swelling and tenderness
■ reduced grip strength, inability to make a fist
○ reduced functional status, inability to do ADLs
○ systemic:
■ profound fatigue (afternoon), poor sleep
■ decreased energy
■ possible weight loss &/or low-grade fever

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pattern of Joints Affected
Prognosis

A

proximal interphalangeal joints = PIP
metacarpal phalangeal joints = MCP
Pattern of Joints Affected
metatarsal phalangeal joints = MTP
almost any joint
can be in fact affected the one
exception is the spine so patients with
rheumatoid arthritis do not have back
pain that’s associated with that
rheumatoid arthritis

Joint Deformity: due to prolonged joint inflammation
Swan Neck Deformity
Boutonnière Deformity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Associated Signs/Symptoms

A

Ø RA affects more than the joints; it’s a systemic disease

Anemia * normocytic or hypochromic/microcytic
* multifactorial: chronic inflammation, bone
marrow suppression (meds), blood loss
Eyes * keratoconjunctivitis sicca (dry eyes)
Nervous System * carpal tunnel syndrome, tarsal tunnel syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Extra-Articular Manifestations

A

Rheumatoid
Nodule
Rheumatoid
Nodule
Baker’s cyst
(aka popliteal)

they’re not the same as a joint deformity they’re
often asymptomatic and don’t require
specific treatment so they are local
sort of swelling or lumps they’re
painless but they might restrict
movement when you press on them

They can occur on the the pressure points so near inflamed joints

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Potential Complications

A

Cardiovascular
Disease
* associated with traditional & RA specific risk factors
* ~1.5 fold higher than general population

Infections * historically ~2 fold higher (URTI, those requiring hospitalization)
* herpes zoster risk ~1.5-3 fold higher

Cancer * ~2 fold higher risk of lymphoma; also lung
cancer and perhaps melanoma

Osteoporosis * 2 fold higher risk of hip/vertebral #
* surrounding affected joints > globally (steroids, inactivity)

Systemic inflamm, also increased incidince of hypertension dyslipidemia and diabetes

potentially both disease related and
treatment related so traditionally patients with rheumatoid arthritis have a higher risk of lymphoma but also lung cancer and perhaps melanomas with good treatment we’ve seen the incidence of these decrease

the bones are are weaker so surrounding affected joints but also globally and this might be related to steroid treatment
or they’ve got more severe disease that limits their
activity they’re not as able to do the things that we know help to prevent osteoporosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Common Comorbidities

A

depression
asthma
GI ulcer
any solid cancer
any skin cancer
MI, stroke, lymphoma
Hep B and C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Consider Sarah:
Which signs and symptoms does Sarah have that fit
with a diagnosis of RA?
Signs Symptoms
What RA risk factors does she have?

A

ok

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How is RA diagnosed?

A

● History, physical exam, lab tests (and x-rays)
● Need to ‘rule out’ other diagnoses:
○ Osteoarthritis
○ Bursitis, tendonitis
○ Infection
○ Fibromyalgia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Differentiating RA and OA

A

Inflammatory Non-inflammatory
Joint pain
With activity and at rest With activity

Joint swelling
Soft tissue Bony

Joint deformity
Common Common

Local erythema
Sometimes Absent

Local warmth
Frequent Absent

Morning stiffness
> 30 min < 30 min

Systemic symptoms
Common, especially fatigue Absent

17
Q

Clinical Investigations

A

● History and Physical
○ refer to Clinical Presentation and Patterns of Joints Affected
● Laboratory Findings
○ (+) rheumatoid factor
■ 90% specific, 80% sensitive
○ (+) anti-cyclic citrullinated peptide antibody (ACPA or aCCP)
■ 95% specific, 70% sensitive
○ CRP >8 mg/L (ESR >20-30 mm/h)
○ CBC: ›WBC, œHb, ›platelets

autoantibodies are quite specific
for rheumatoid arthritis but not
perfectly sensitive which means that not
all patients will be positive for one or
both Auto antibodies and some patients
who actually don’t have a diagnosis of
rheumatoid arthritis will be positive
for one of these

systemic inflammation with an
elevated CRP which we use more often
than ESR now because it is a little bit
more specifi

18
Q

Clinical Investigations
Diagnostic Imaging

A

Early:
periarticular
swelling, joint
effusions
Intermediate:
uniform joint space
narrowing and
marginal erosions
Late:
malalignment
due to joint
damage,
periarticular
osteopenia, and

19
Q

Measuring Response: ACR20

A
  • ACR Criteria: outline minimum core set of variables to consider in determining
    response to or remission with therapy

ACR-20 Response
* >20% improvement in:
* tender joint count
* swollen joint count
* 3 of the following:
* patient pain assessment
* patient global assessment
* physician global assessment
* patient self-assessment of disability
(HAQ score)
* acute phase reactant (ESR or CRP)

Remission
* absence of joint inflammation &
disease activity
* >5 criteria present for >2 months
* morning stiffness <15min
* no fatigue
* no joint pain
* no joint tenderness or pain on motion
* no soft tissue swelling in joints or
tendon sheaths
* ESR <30 (female) or <20 (male)

ACR 20 response would be consideredthe minimal response for any particular drug therapy so this means essentially a patient is 20 better so they’ve seen a 20 decrease in their tender and swollen joint count
ideally we’re measuring remission so this is the complete absence of joint inflammation and disease activity and at least five of these bullets these criteria are present for at least two months

20
Q

Measuring Response: DAS28

A

Disease Activity Score in 28 joints (DAS-28)
○ systematic use in follow up has been shown to increase likelihood of achieving
low-disease activity through more frequent drug and dose changes
● Scoring: 0-9.4 (continuous scale)
○ includes measurement of swollen & tender (28) joint count, ESR or CRP, and
patient global assessment of disease activity (VAS 0-100)
○ Check it out! www.rheumdas.com

● Thresholds of disease activity levels:
○ Remission: <2.6
○ Low activity: ≥2.6 to <3.2
○ Moderate activity: ≥3.2 to ≤5.1
○ High activity: >5.1

21
Q

Measuring Response: HAQ

A

Health Assessment Questionnaire Disability Index
● patient reported measure of disease activity
○ provides intrinsic knowledge about a patient’s health, functional status,
symptoms, treatment preferences, satisfaction, and QoL
● Short HAQ most commonly used
1. Disability Index (HAQ-DI):
■ 10 questions focusing on functional ability (bADLs) (scored 0-3)
2. Pain Scale (VAS):
■ presence/absence of arthritis related pain & its severity over the past week (scored 0-3 or
0-100)
3. Patient Global Health Scale (VAS):
■ considers all the ways arthritis affects the patient (scored 0-100)
Check it out! rheuminfo.com/docs/physician-tools/HAQ-II1.pdf